OWLT — Owlet, Inc.

Summary of Owlet (OWLT) Q4 and Full Year 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 2025 Revenue: $26.6 million, up 29.6% year-over-year.
• Full Year 2025 Revenue: $105.7 million, a record high, representing a 35.4% increase from 2024.
• Q4 Gross Margin: 47.6%, impacted by tariffs (510 basis points).
• Full Year Gross Margin: 50.6%, also a record, exceeding guidance.
• Q4 Adjusted EBITDA: $0.1 million, down from $0.5 million in Q4 2024, primarily due to tariff costs.
• Full Year Adjusted EBITDA: $2 million, a $3.8 million improvement over 2024.
• Cash Position: $35.5 million as of December 31, 2025, up from $23.8 million in Q3 2025.

2. Strategic Updates and Business Highlights

• Owlet360 Subscription Service: Launched in January 2025, now has over 110,000 paying subscribers. International subscription offerings have begun, expanding revenue streams.
• Dream Sight Camera: Launched in September 2025, features AI capabilities and is expected to enhance customer lifetime value (LTV) and subscription growth.
• Market Share Growth: Owlet captured 41% of the baby monitor market, a significant increase from 24% year-over-year.
• International Expansion: Q4 international revenue reached $3.9 million, with significant growth in the U.K., France, and the Nordics. Regulatory clearances obtained for India and Israel.
• Healthcare Partnerships: Expanded collaborations with hospitals and increased Medicaid reimbursement coverage to 37 states.

3. Forward Guidance and Outlook

• Q1 2026 Revenue Guidance: Expected between $20 million to $21 million, acknowledging typical seasonality and a strong prior year due to RSV and flu.
• Full Year 2026 Revenue Guidance: Projected between $126 million to $130 million, reflecting 19% to 23% growth over 2025.
• Adjusted EBITDA for 2026: Expected between $3 million to $5 million, indicating growth of 50% to 150% over 2025.
• Gross Margin Expectations: Forecasted between 49% to 52% for 2026, with ongoing tariff impacts considered.

4. Bad News, Challenges, or Points of Concern

• Tariff Impact: Continued tariff costs are expected to affect margins, with a consistent impact of approximately 510 basis points per quarter.
• Consumer Spending Softness: Observed during the Q4 holiday period, potentially affecting sales in early 2026.
• Seasonality: Q1 is typically the weakest quarter, which may contribute to lower revenue expectations compared to previous years.
• Regulatory Environment: Ongoing uncertainty with the FDA and its communications could pose risks, although market share has continued to grow.

5. Notable Q&A Insights

• Guidance Clarification: Management acknowledged that Q1 revenue expectations are lower due to seasonality and macroeconomic pressures, but they remain confident in long-term demand.
• AI Integration: Plans to leverage AI for personalized insights and enhanced subscription features, which could improve customer retention and engagement.
• International Revenue Expectations: Future international sales are anticipated to ramp up in the first half of 2026, with subscription growth expected as new markets are entered.
• Telehealth Platform: The Owlet OnCall Telehealth platform is set to launch in the second half of 2026, positioned as an upsell to the Owlet360 subscription, aimed at enhancing care quality through real-time data sharing.

Overall, Owlet reported a strong performance in 2025, with significant growth in revenue and market share, while also outlining strategic initiatives for future expansion despite facing challenges from tariffs and market conditions.